You Searched For "alzheimer s drugs" and got 20 results
Sort By:
3 mins read
Viagra gets an image make-over as successive studies claim it helps with dementia and Alzheimer’s disease
If there’s one thing most of us love, it’s the whole “buy one, get one free” schtick. What if we to…
2 mins read
Weight-loss drugs like Ozempic could help slow biological aging, researchers say
Physicians warn that weight-loss drugs such as Ozempic and Wegovy come with a risk of severe side e…
Rebecca Rommen
4 mins read
Scientists say weight-loss drugs could protect our brains from dementia. Early results suggest they're onto something.
Patients with Alzheimer's who took a GLP-1 drug improved their memory scores and lost less of their…
Hilary Brueck
2 mins read
Another perk of weight-loss drugs? Eli Lilly's Zepbound may alleviate sleep apnea, too
The new class of weight-loss drugs isn't just for diabetes and weight loss. Eli Lilly results from …
Hilary Brueck
2 mins read
A man who took new the Alzheimer's drug donanemab said it gave him the confidence to sing at his 80th birthday party
Mike Colley performed Frank Sinatra's "My Way" for a crowd of 40 after taking Eli Lilly's new Alzhe…
Kim Schewitz
4 mins read
The FDA just approved a new Alzheimer's drug that's set to be a blockbuster
The new drug, called Leqembi, slowed the rate of cognitive decline in Alzheimer's patients by 27%.
Yeji Jesse Lee
2 mins read
New Alzheimer's drug slows cognitive decline, clinical trial finds
Lecanemab, a drug made by Eisai and Biogen, was observed in a large-scale trial to have slowed the …
Cheryl Teh
3 mins read
The promising new Alzheimer's drugs to watch — and the far-out ideas that could reshape how we treat the disease
Two Alzheimer's drugs, Biogen's Leqembi and Eli Lilly's donanemab, treat the disease by focusing on…
Yeji Jesse Lee
3 mins read
An experimental drug just showed it can help slow Alzheimer's, offering new hope for patients and a major boost to pharma giant Eli Lilly
In a late-stage trial, Eli Lilly's experimental Alzheimer's treatment slowed the rate of cognitive …
Yeji Jesse Lee
4 mins read
We read through the 45-page congressional investigation into Biogen's Alzheimer's drug. Here are the 3 most shocking takeaways.
The investigation found that Biogen knew the drug's hefty price tag would make the medication inacc…
Yeji Jesse Lee,Leah Rosenbaum
2 mins read
Expect AI-made prescription drugs to be ready for clinical trials in a couple of years, predicts Google DeepMind CEO
"I think we are very close," Google Deepmind's CEO said when asked if AI could help cure a major di…
Sarah Jackson
4 mins read
This Alzheimer’s drug slowed cognitive decline in some patients. Analysts say it could become a blockbuster hit.
Full results of Biogen and Eisai's Alzheimer's study on lecanemab give some credence to a controver…
Yeji Jesse Lee
3 mins read
As gene-editing moves mainstream, a pioneer in the field is testing whether it could prevent Alzheimer's
Scientist David Liu has developed two ways to edit human DNA. He's testing whether they can be used…
Allison DeAngelis
6 mins read
Getting hot new weight-loss drugs like Wegovy will still be a struggle in 2024
Patients and doctors want weight-loss shots like Wegovy to be more accessible. But it seems like t…
Shelby Livingston
2 mins read
Chris Hemsworth shares 4 things he does for longevity and to protect his brain health after discovering his Alzheimer's risk
Chris Hemsworth found out while filming his docuseries "Limitless" that he has a gene that may make…
Rachel Hosie
2 mins read
Biogen soars 43% after its Alzheimer's drug helps slow down cognitive decline in late-stage study
JPMorgan estimates the Alzheimer's drug could generate between $6 billion and $10 billion in peak s…
Matthew Fox
2 mins read
A small drugmaker's stock tumbles 30% after a lawyer questions its experimental Alzheimer's treatment
Cassava is a lesser-known meme stock that surged 910% at one point on optimism for its early-stage …
Shalini Nagarajan
2 mins read
Biogen sinks 10% after Medicare limits coverage of new Alzheimer's drug Aduhelm
Medicare seeks to only cover patients who are enrolled in clinical trials evaluating Aduhelm, a dru…
Carla Mozée
2 mins read
Read the FDA report on the death of a woman who was taking a new Alzheimer's drug, reigniting safety concerns
These are Insider's biggest healthcare stories for December 13.
Leah Rosenbaum
3 mins read
Eli Lilly rides the weight-loss-drug wave to a new record high, and is now worth more than $700 billion
"We haven't scratched the surface in terms of how big the [GLP-1 weight loss] drugs are going to ge…